Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
134 USD | -2.30% | -4.48% | +6.29% |
05-03 | European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower | MT |
05-03 | Ascendis Pharma Q1 Net Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.29% | 7.84B | |
+8.95% | 105B | |
-0.49% | 104B | |
+5.79% | 22.94B | |
-12.73% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-8.78% | 16.96B | |
+8.29% | 14.16B | |
+39.67% | 12.63B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Citigroup Adjusts Ascendis Pharma's Price Target to $158 From $187, Reiterates Buy Rating